Interleukin-10 (IL-10) is emerging as a promising cancer immunotherapy due to its ability to boost exhausted immune cells (CD8+ T cells), helping them fight tumors more effectively while also reducing harmful inflammation. This evidence concerns the gene IL10 and cancer.